NWF Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

NWF Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$491K	Sell	1,300 -300	-19%	-$105K	0.05%	227
2026 Q2	$470K	Sell	1,600 -80	-5%	-$22.7K	0.04%	234
2026 Q1	$468K	Hold	1,680	–	–	0.05%	220
2025 Q4	$509K	Hold	1,680	–	–	0.06%	209
2025 Q3	$471K	Sell	1,680 -100	-6%	-$27.2K	0.05%	222
2025 Q2	$430K	Hold	1,780	–	–	0.05%	232
2025 Q1	$434K	Buy	+1,780	New	+$535K	0.06%	192
2024 Q4	–	Sell	-1,780	Closed	-$596K	–	299
2024 Q3	$596K	Hold	1,780	–	–	0.09%	147
2024 Q2	$486K	Hold	1,780	–	–	0.08%	161
2024 Q1	$616K	Hold	1,780	–	–	0.1%	140
2023 Q4	$575K	Hold	1,780	–	–	0.11%	133
2023 Q3	$638K	Hold	1,780	–	–	0.15%	112
2023 Q2	$675K	Hold	1,780	–	–	0.16%	112
2023 Q1	$675K	Buy	+1,780	New	+$833K	0.16%	112

Other funds holding BIO

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return

Arnhold LLC New York $1.4B AUM 42.37% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Marathon Asset Management (UK) London, United Kingdom $2.2B AUM 25.78% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return

NWF Advisory Services's BIO Position: Q3 2026 in Review

NWF Advisory Services reduced its Bio-Rad Laboratories Class A (BIO) stake by 19% in Q3 2026, selling an estimated $105K and leaving 1,300 shares worth $491K. The position accounts for 0.05% of the portfolio, ranked #227.

NWF Advisory Services first reported a position in BIO in Q1 2023 and has held it in 14 quarters since. The position peaked at $675K in Q2 2023. 80 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

NWF Advisory Services held 1,300 shares of Bio-Rad Laboratories Class A worth $491K as of Q3 2026.
NWF Advisory Services sold 300 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $105K.
Bio-Rad Laboratories Class A made up 0.05% of NWF Advisory Services's portfolio in Q3 2026, its #227 holding.
NWF Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and has held it in 14 quarters since.
NWF Advisory Services's Bio-Rad Laboratories Class A position peaked at $675K in Q2 2023.
80 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on NWF Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.